Pharming Group N.V. (PHAR)

Market price: $11.87

5 valuation methods

• EV / EBITDA: $4.27 to $7.57 (midpoint $5.69)
• P / B: $7.33 to $23.51 (midpoint $12.20)
• EV / Revenue: $8.66 to $26.67 (midpoint $14.60)
• DCF (FCFF): $16.33 to $18.82 (midpoint $17.42)
• EV / Gross Profit: $14.36 to $38.85 (midpoint $24.18)